Catriona Yale

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Jonathan Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catriona Yale:

Company Role Class Num Shares Value Price $ Report Date Ownership
Akero Therapeutics, Inc. Chief Development Officer Common Stock 0 $0 $54.31 09 Dec 2025 Direct
Akero Therapeutics, Inc. Chief Development Officer Stock Option (Right to Buy) 0 09 Dec 2025 Direct

Insider Reports Filed by Catriona Yale

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKRO Akero Therapeutics, Inc. 09 Dec 2025 11 $0 4 Chief Development Officer 09 Dec 2025, 10:06
AKRO Akero Therapeutics, Inc. 04 Nov 2025 4 +$199,983 4 Chief Development Officer 06 Nov 2025, 07:00
AKRO Akero Therapeutics, Inc. 11 Sep 2025 1 -$28,350 4 Chief Development Officer 12 Sep 2025, 20:39
AKRO Akero Therapeutics, Inc. 16 Jul 2025 4 -$330,767 4 Chief Development Officer 18 Jul 2025, 18:00
AKRO Akero Therapeutics, Inc. 30 Jun 2025 1 +$21,243 4 Chief Development Officer 02 Jul 2025, 18:00
AKRO Akero Therapeutics, Inc. 18 Jun 2025 1 -$89,554 4 Chief Development Officer 20 Jun 2025, 21:07
AKRO Akero Therapeutics, Inc. 16 Jun 2025 5 -$331,306 4 Chief Development Officer 20 Jun 2025, 09:22
AKRO Akero Therapeutics, Inc. 10 Jun 2025 1 -$151,351 4 Chief Development Officer 12 Jun 2025, 18:33
AKRO Akero Therapeutics, Inc. 15 May 2025 5 -$181,978 4 Chief Development Officer 19 May 2025, 19:06
AKRO Akero Therapeutics, Inc. 15 Apr 2025 4 -$152,522 4 Chief Development Officer 16 Apr 2025, 18:00
AKRO Akero Therapeutics, Inc. 17 Mar 2025 4 -$236,605 4 Chief Development Officer 18 Mar 2025, 17:30
AKRO Akero Therapeutics, Inc. 12 Mar 2025 1 -$27,556 4 Chief Development Officer 14 Mar 2025, 20:30
AKRO Akero Therapeutics, Inc. 18 Feb 2025 4 -$287,660 4 Chief Development Officer 21 Feb 2025, 17:31
AKRO Akero Therapeutics, Inc. 27 Jan 2025 10 -$2,452,409 4 Chief Development Officer 31 Jan 2025, 09:14
AKRO Akero Therapeutics, Inc. 27 Jan 2025 7 -$1,698,751 4 Chief Development Officer 31 Jan 2025, 09:14
AKRO Akero Therapeutics, Inc. 16 Dec 2024 5 -$72,656 4 Chief Development Officer 18 Dec 2024, 21:01
AKRO Akero Therapeutics, Inc. 10 Dec 2024 1 -$86,520 4 Chief Development Officer 12 Dec 2024, 20:28
AKRO Akero Therapeutics, Inc. 15 Nov 2024 4 -$60,087 4 Chief Development Officer 19 Nov 2024, 21:57
AKRO Akero Therapeutics, Inc. 06 Nov 2024 4 -$345,740 4 Chief Development Officer 08 Nov 2024, 17:06
AKRO Akero Therapeutics, Inc. 30 Oct 2024 6 -$229,960 4 Chief Development Officer 01 Nov 2024, 20:59
AKRO Akero Therapeutics, Inc. 14 Oct 2024 8 -$624,298 4 Chief Development Officer 16 Oct 2024, 20:06
AKRO Akero Therapeutics, Inc. 19 Sep 2024 3 -$148,704 4 Chief Development Officer 23 Sep 2024, 18:00
AKRO Akero Therapeutics, Inc. 16 Sep 2024 9 -$226,013 4 Chief Development Officer 18 Sep 2024, 21:19
AKRO Akero Therapeutics, Inc. 10 Sep 2024 1 -$16,677 4 Chief Development Officer 13 Sep 2024, 17:14
AKRO Akero Therapeutics, Inc. 03 Sep 2024 3 -$25,622 4 Chief Development Officer 05 Sep 2024, 16:05
AKRO Akero Therapeutics, Inc. 23 Aug 2024 6 -$378,073 4 Chief Development Officer 28 Aug 2024, 11:11
AKRO Akero Therapeutics, Inc. 28 Jun 2024 1 +$21,217 4 Chief Development Officer 02 Jul 2024, 18:56
AKRO Akero Therapeutics, Inc. 11 Jun 2024 1 -$63,961 4 Chief Development Officer 13 Jun 2024, 18:11
AKRO Akero Therapeutics, Inc. 13 Mar 2024 1 -$20,483 4 Chief Development Officer 15 Mar 2024, 16:45
AKRO Akero Therapeutics, Inc. 04 Mar 2024 5 -$444,602 4 Chief Development Officer 06 Mar 2024, 20:13
AKRO Akero Therapeutics, Inc. 14 Dec 2023 1 -$12,394 4 Chief Development Officer 18 Dec 2023, 20:49
AKRO Akero Therapeutics, Inc. 08 Dec 2023 2 $0 4 Chief Development Officer 12 Dec 2023, 16:26
AKRO Akero Therapeutics, Inc. 13 Sep 2023 5 -$239,616 4 Chief Development Officer 25 Sep 2023, 21:31
AKRO Akero Therapeutics, Inc. 28 Aug 2023 4 -$250,652 4 Chief Development Officer 30 Aug 2023, 20:04
AKRO Akero Therapeutics, Inc. 21 Jun 2023 4 -$1,725,390 4 Chief Development Officer 23 Jun 2023, 20:06
AKRO Akero Therapeutics, Inc. 13 Jun 2023 1 -$32,600 4 Chief Development Officer 15 Jun 2023, 21:29
AKRO Akero Therapeutics, Inc. 10 Mar 2023 1 -$30,465 4 Chief Development Officer 14 Mar 2023, 16:20
AKRO Akero Therapeutics, Inc. 13 Jan 2023 4 -$252,651 4 Chief Development Officer 18 Jan 2023, 16:30
AKRO Akero Therapeutics, Inc. 16 Dec 2022 1 $0 4 Chief Development Officer 20 Dec 2022, 18:52
AKRO Akero Therapeutics, Inc. 09 Dec 2022 4 -$216,137 4 Chief Development Officer 13 Dec 2022, 19:24
AKRO Akero Therapeutics, Inc. 10 Nov 2022 2 -$197,105 4 Chief Development Officer 14 Nov 2022, 16:26
AKRO Akero Therapeutics, Inc. 10 Oct 2022 1 -$189,950 4 Chief Development Officer 12 Oct 2022, 16:59
AKRO Akero Therapeutics, Inc. 13 Sep 2022 2 -$1,099,228 4 Chief Development Officer 15 Sep 2022, 19:59
AKRO Akero Therapeutics, Inc. 09 Sep 2022 3 +$9,251 4 Chief Development Officer 13 Sep 2022, 21:15
AKRO Akero Therapeutics, Inc. 08 Dec 2021 1 $0 4 Chief Development Officer 10 Dec 2021, 16:08
AKRO Akero Therapeutics, Inc. 15 Oct 2021 2 -$269,826 4 Chief Development Officer 18 Oct 2021, 16:21
AKRO Akero Therapeutics, Inc. 15 Sep 2021 2 -$308,605 4 Chief Development Officer 17 Sep 2021, 16:05
AKRO Akero Therapeutics, Inc. 16 Aug 2021 1 -$187,900 4 Chief Development Officer 17 Aug 2021, 21:15
AKRO Akero Therapeutics, Inc. 15 Jul 2021 1 -$209,044 4 Chief Development Officer 19 Jul 2021, 16:43